Field Trip Health Ltd.
FTRP · NASDAQ
6/30/2022 | 3/31/2022 | 12/31/2021 | 9/30/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.01 | 0.07 | -0.03 | -0.35 |
| FCF Yield | -85.71% | -56.74% | -34.92% | -18.08% |
| EV / EBITDA | 6.96 | 1.21 | -3.11 | -5.38 |
| Quality | ||||
| ROIC | -25.20% | -14.37% | -14.14% | -13.25% |
| Gross Margin | 0.00% | -56.09% | -87.14% | -111.26% |
| Cash Conversion Ratio | 0.80 | 0.73 | 0.75 | 0.90 |
| Growth | ||||
| Revenue 3-Year CAGR | 445.49% | 1,593.89% | 1,541,358.53% | 1,378,131.30% |
| Free Cash Flow Growth | 1.98% | 12.46% | -4.06% | -1.26% |
| Safety | ||||
| Net Debt / EBITDA | 10.11 | 2.74 | -0.47 | 0.23 |
| Interest Coverage | -765.92 | -37.06 | -45.65 | -57.43 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 64.15 | 72.10 | 244.30 |